Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer

SIMPLE SUMMARY: Salivary gland cancer is rare and there is a need to develop new and effective drug therapies. New drugs are in development in the recurrent and metastatic setting that target specific changes within a cancer, some of which can be detected through sequencing of the cancer DNA. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rack, Samuel, Feeney, Laura, Hapuarachi, Brindley, Adderley, Helen, Woodhouse, Laura, Betts, Guy, Burghel, George J., Harrington, Kevin J., Metcalf, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909363/
https://www.ncbi.nlm.nih.gov/pubmed/35267442
http://dx.doi.org/10.3390/cancers14051133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909363/
https://www.ncbi.nlm.nih.gov/pubmed/35267442
http://dx.doi.org/10.3390/cancers14051133

Ejemplares similares